Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Levelt, E., Piechnik S. K., Liu A., Wijesurendra R. S., Mahmod M., Ariga R., et al. (2017).  Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.. J Cardiovasc Magn Reson. 19(1), 81.
Mahmod, M., Piechnik S. K., Levelt E., Ferreira V. M., Francis J. M., Lewis A., et al. (2014).  Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values.. J Cardiovasc Magn Reson. 16, 92.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.. J Thromb Thrombolysis. 41(2), 336-42.
Tziomalos, K. (2016).  Adherence to antihyperglycemic treatment: a work in progress.. Expert Opin Pharmacother. 17(12), 1579-80.
Cindolo, L., Spiess P. E., Bada M., Chipollini J. J., Nyirády P., Chiodini P., et al. (2019).  Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study.. World J Urol. 37(8), 1649-1657.
Manika, A., Hatziagorou E., Kotoulas S-C., Kyrvasili S-S., Sourla E., Kouroukli E., et al. (2022).  Adherence to inhaled therapies over 4 years in people with cystic fibrosis.. Pediatr Pulmonol. 57(4), 956-964.
Buvat, J., Büttner H., Hatzimouratidis K., Vendeira P. A. S., Moncada I., Boehmer M., et al. (2013).  Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.. J Sex Med. 10(6), 1592-602.
Liakos, C. I., Papadopoulos D. P., & Kotsis V. T. (2017).  Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice. Am J Cardiovasc Drugs. 17(5), 391-398.
Polyzos, S. A., Kountouras J., Papatheodorou A., Katsiki E., Patsiaoura K., Zafeiriadou E., et al. (2013).  Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.. Ann Hepatol. 12(5), 749-57.
Polyzos, S. A., Kountouras J., Zavos C., & Stergiopoulos C. (2010).  Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.. Med Hypotheses. 74(6), 1089-90.
Petridou, E. Th, Dessypris N., Panagopoulou P., Sergentanis T. N., Mentis A-F. A., Pourtsidis A., et al. (2010).  Adipocytokines in relation to Hodgkin lymphoma in children.. Pediatr Blood Cancer. 54(2), 311-5.
Comasco, E., Iliadis S. I., Larsson A., Olovsson M., Oreland L., Sundström-Poromaa I., et al. (2013).  Adipocytokines levels at delivery, functional variation of TFAP2β, and maternal and neonatal anthropometric parameters.. Obesity (Silver Spring). 21(10), 2130-7.
Kadoglou, N. P. E., Sailer N., Moumtzouoglou A., Kapelouzou A., Gerasimidis T., Kostakis A., et al. (2012).  Adipokines: a novel link between adiposity and carotid plaque vulnerability.. Eur J Clin Invest. 42(12), 1278-86.
Savopoulos, C., Michalakis K., Apostolopoulou M., Miras A., & Hatzitolios A. (2011).  Adipokines and stroke: a review of the literature.. Maturitas. 70(4), 322-7.
Katsiki, N., Yovos J. G., Gotzamani-Psarrakou A., & Karamitsos D. T. (2011).  Adipokines and vascular risk in type 2 diabetes mellitus.. Angiology. 62(8), 601-4.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2016).  Adipokines in nonalcoholic fatty liver disease.. Metabolism. 65(8), 1062-79.
Boutari, C., Tziomalos K., & Athyros V. G. (2016).  The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease.. Hippokratia. 20(4), 259-263.
Spanos, N., Tziomalos K., Macut D., Koiou E., Kandaraki E. A., Delkos D., et al. (2012).  Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.. Obes Facts. 5(4), 495-504.
Anagnostis, P., Katsiki N., Athyros V. G., & Karagiannis A. (2014).  Adiponectin and Aldosterone in Left Ventricular Hypertrophy: An Intriguing Interplay.. Angiology.
Panagopoulou, P., Fotoulaki M., Manolitsas A., Pavlitou-Tsiontsi E., Tsitouridis I., & Nousia-Arvanitakis S. (2008).  Adiponectin and body composition in cystic fibrosis.. J Cyst Fibros. 7(3), 244-51.
Panagopoulou, P., Galli-Tsinopoulou A., Fleva A., Pavlitou-Tsiontsi E., Vavatsi-Christaki N., & Nousia-Arvanitakis S. (2008).  Adiponectin and insulin resistance in childhood obesity.. J Pediatr Gastroenterol Nutr. 47(3), 356-62.
Karras, S. N., Polyzos S. A., Newton D. A., Wagner C. L., Hollis B. W., van den Ouweland J., et al. (2018).  Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates.. Endocrine. 59(1), 164-174.
Karras, S. N., Polyzos S. A., Tsekmekidou X., Gerou S., Gavana E., Papageorgiou V., et al. (2019).  Adiponectin and vitamin D-binding protein concentrations are independently associated in apparently healthy women but not men: a validation cohort.. Hormones (Athens). 18(1), 99-102.
Polyzos, S. A., Kountouras J., & Zavos C. (2010).  Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis.. Hepatol Res. 40(4), 446-7.
Polyzos, S. A., & Mantzoros C. S. (2016).  Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review.. Metabolism. 65(9), 1297-306.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές